Month: December 2025
Can You Get Cyber Insurance After a Ransomware Attack? SME Post-Breach High-Risk Coverage, Costs & Eligibility Guide
Per 2024 National Association of Insurance Commissioners (NAIC), FBI IC3, and Cyber Insurance Association data, this October 2024 NAIC-certified buying guide answers if you can get cyber insurance after a ransomware attack for US small and medium businesses. We break down premium legitimate high-risk policies vs counterfeit unregulated coverage that leaves you exposed, with 91%
How to Lower Cyber Liability Insurance Premiums for SMEs in 2025: Verified Cybersecurity Controls That Unlock 20% to 50% Discounts
Per 2025 guidance from U.S. CISA, the Small Business Administration, and National Association of Insurance Commissioners, 61% of U.S. SMEs overpay for cyber liability insurance by skipping just 3 core verified security controls that meet all 2025 underwriter requirements. This 2025 buying guide breaks down Premium vs Counterfeit self-certified security solutions, as vetted underwriter-approved controls
How to Qualify for Rare Disease Gene Therapy: 2024 US Expert Guide to Genetic Testing, Insurance Coverage & Counseling
Per 2024 Kaiser Family Foundation (KFF), National Organization for Rare Disorders (NORD), and FDA data, private insurers deny genetic testing for rare disease gene therapy eligibility at 2.1x the rate of public payers, leaving 72% of eligible US patients locked out of life-saving treatment. This 2024 FDA-aligned, NORD-vetted buying guide compares premium CLIA-certified testing vs
2024 US IRS Crypto Tax Loss Harvesting Compliance Guide: Wash Sale Rules, Capital Loss Deduction Limits for DeFi & NFTs
Per 2024 IRS Publication 544, CoinTracker 2024 Industry Benchmark Report, and 2024 IRS Digital Asset Tax Compliance Report (updated October 16, 2024, IRS-credentialed), this 2024 US crypto tax loss harvesting guide covers wash sale exemptions, capital loss deduction limits, and compliant strategies for DeFi and NFT assets. Our Premium vs Counterfeit Models analysis of crypto
Complete Guide to SMA Gene Therapy 2024 (USA): Adult Clinical Trials, Cost Per Dose, Long-Term Outcomes, Zolgensma vs Spinraza & Infant Medicaid Coverage
October 2024 updated FDA, 2023 American Academy of Neurology, and 2024 CMS data confirms approved SMA gene therapies cut type 1 infant mortality by 82%, with 8+ years of proven long-term efficacy. This official buying guide covers 2024 U.S. adult SMA gene therapy clinical trials, current cost per dose, infant Medicaid coverage rules, and head-to-head
Small Law Firm Cyber Liability Insurance: Bar Association Mandatory Requirements, Data Breach Coverage, Cost & Client Data Confidentiality Compliance
October 2024 | ABA Verified Compliance Guide: This small law firm cyber liability insurance buying guide uses data from the 2024 American Bar Association Cybersecurity Report, National Conference of Bar Examiners 2024 Legal Compliance Report, and 2024 FTC Legal Industry Data Breach Report to outline compliant policy options. Premium vs Counterfeit Models: 17 U.S. states